JPS6234759B2 - - Google Patents

Info

Publication number
JPS6234759B2
JPS6234759B2 JP59162761A JP16276184A JPS6234759B2 JP S6234759 B2 JPS6234759 B2 JP S6234759B2 JP 59162761 A JP59162761 A JP 59162761A JP 16276184 A JP16276184 A JP 16276184A JP S6234759 B2 JPS6234759 B2 JP S6234759B2
Authority
JP
Japan
Prior art keywords
cymetidine
item
solvent
items
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59162761A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60185767A (ja
Inventor
Mikaeru Gai Babin Patoritsuku
Kurisutofuaa Fuiritsupusu Surei Jeimuzu
Deibitsudo Tobei Jofurii
Jon Uoodo Richaado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK PLC
Original Assignee
GlaxoSmithKline PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10407431&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS6234759(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3906576A external-priority patent/GB1543238A/en
Application filed by GlaxoSmithKline PLC filed Critical GlaxoSmithKline PLC
Publication of JPS60185767A publication Critical patent/JPS60185767A/ja
Publication of JPS6234759B2 publication Critical patent/JPS6234759B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP59162761A 1976-09-21 1984-07-31 複素環式化合物の新規多形体 Granted JPS60185767A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB39065/76 1976-09-21
GB3906576A GB1543238A (en) 1976-09-21 1976-09-21 Polymorph of cimetidine
GB2716/77 1977-01-24

Publications (2)

Publication Number Publication Date
JPS60185767A JPS60185767A (ja) 1985-09-21
JPS6234759B2 true JPS6234759B2 (de) 1987-07-28

Family

ID=10407431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59162761A Granted JPS60185767A (ja) 1976-09-21 1984-07-31 複素環式化合物の新規多形体

Country Status (18)

Country Link
JP (1) JPS60185767A (de)
AR (1) AR218267A1 (de)
BG (1) BG28050A3 (de)
CS (1) CS207482B1 (de)
DD (1) DD129906A5 (de)
DK (1) DK417677A (de)
ES (1) ES462517A1 (de)
FI (1) FI772542A7 (de)
GR (1) GR61173B (de)
IT (1) IT1086352B (de)
MY (1) MY8400026A (de)
NL (1) NL7710354A (de)
NO (1) NO773225L (de)
PL (1) PL103681B1 (de)
PT (1) PT66927B (de)
SE (1) SE7710518L (de)
ZA (1) ZA774857B (de)
ZM (1) ZM7077A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1531221A (en) * 1974-09-02 1978-11-08 Smith Kline French Lab Process for preparing guanidine derivatives

Also Published As

Publication number Publication date
PT66927A (en) 1977-09-01
SE7710518L (sv) 1978-03-22
BG28050A3 (bg) 1980-02-25
FI772542A7 (de) 1977-08-29
PL103681B1 (pl) 1979-07-31
AR218267A1 (es) 1980-05-30
NL7710354A (nl) 1978-03-23
ZA774857B (en) 1978-06-28
PL200960A1 (pl) 1978-05-22
IT1086352B (it) 1985-05-28
ES462517A1 (es) 1978-07-01
DD129906A5 (de) 1978-02-15
JPS60185767A (ja) 1985-09-21
ZM7077A1 (en) 1978-08-21
NO773225L (no) 1978-03-22
CS207482B1 (en) 1981-07-31
PT66927B (en) 1979-03-13
MY8400026A (en) 1984-12-31
DK417677A (da) 1978-03-22
GR61173B (en) 1978-10-03

Similar Documents

Publication Publication Date Title
US6730326B2 (en) Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
JP2009280604A (ja) Ｎ−（４−トリフルオロメチルフェニル）−５−メチルイソオキサゾール−４−カルボキサミドの結晶形態の製造方法
KR100336229B1 (ko) 열역학적으로 안정한1-(4-카바졸릴옥시)-3-[2-(2-메톡시페녹시)에틸아미노]-2-프로판올의 개질물, 이의 제조 방법 및 이를 함유한 약학조성물
JPS6222967B2 (de)
Kshirsagar et al. Process intensification of atorvastatin calcium crystallization for target polymorph development via continuous combined cooling and antisolvent crystallization using an oscillatory baffled crystallizer
Han et al. Self-gelation involved in the transformation of resveratrol and piperine from a co-amorphous system into a co-crystal system
HK1040250A1 (en) New crystal modification n of torasemide
CN104284897A (zh) 替卡格雷晶型及其制备方法和用途
CN115417812A (zh) 一种阿西替尼-烟酰胺共晶及其制备方法和应用
CN121318982A (zh) 巴瑞克替尼的晶型及其制备方法
IL125732A (en) Crystalline modification of the compound -1 (-6,2 difluorobenzyl) 1H- - 1, 2, 3 - triazole-4-carboxamide and a medicinal product for the treatment of epilepsy containing it
CN105061420B (zh) 一种jak抑制剂的晶型及其制备方法和应用
JPS6234759B2 (de)
MATSUDA et al. Physicochemical characterization of oxyphenbutazone and solid-state stability of its amorphous form under various temperature and humidity conditions
TWI762825B (zh) 酪胺酸激酶抑制劑的一馬來酸鹽的晶型及其製備方法
AU2018256993B2 (en) Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole
IL31558A (en) 3'-phenylspiro(imidazolidine-2,1'-phthalan)and the tautomer 2-(2-imidazolin-2-yl)benzhydrol and process for their manufacture
Umar et al. Multicomponent crystal of fenofibric acid-saccharin: characterization and antihyperlipidemic effectiveness
HK41697A (en) Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3, 5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester
JP2016535767A (ja) アリサルタン・イソプロキシル非晶形とその調製方法及びその非晶形を含む医薬組成物
AU2023203547A1 (en) Crystals
JP2707012B2 (ja) Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
EP3408264B1 (de) Nilotinib dinitrat (v) und kristalline formen davon
JPS6056996A (ja) ２′―デオキシ―５―トリフルオロメチルウリジン誘導体及びそれを含有する抗腫瘍剤
Fini et al. Effect of the temperature on a hydrate diclofenac salt